The efficacy and nephrotoxicity associated with colistin use in an intensive care unit in Vietnam: Use of colistin in a population of lower body weight

International Journal of Infectious Diseases

Volumn 35, Issue , 2015, Pages 18-23

  Binh, Nguyen Gia ^a   Hayakawa, Kayoko ^b   Co, Dao Xuan ^a   Tuan, Nguyen Dang ^a   Anh, Nguyen Hoang ^c   Thuy, Nguyen Thi Hong ^a   Phuong, Doan Mai ^a   Huong, Nguyen Thi Lien ^c   Thuy, Pham Thi Phuong ^a   Chau, Ngo Qui ^a   Nhung, Pham Hong ^a   Gam, Do Thi Hong ^a   Hai, Duong Thanh ^a   Huong, Tran Thu ^a   Van Anh, Le ^a   Takeshita, Nozomi ^b   Ohmagari, Norio ^b  

^a BACH MAI HOSPITAL   (Viet Nam)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c HANOI UNIVERSITY OF PHARMACY   (Viet Nam)

Author keywords

Asia; Colistin; Hospital acquired infection; ICU; Lower body weight; Nephrotoxicity

Indexed keywords

COLISTIN; CREATININE; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOODSTREAM INFECTION; BODY WEIGHT; CLINICAL ARTICLE; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MALE; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NONHUMAN; PERSONALIZED MEDICINE; VENTILATOR ASSOCIATED PNEUMONIA; VIET NAM; VIETNAMESE; CRITICAL ILLNESS; DRUG EFFECTS; KIDNEY; MIDDLE AGED; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COLISTIN; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; KIDNEY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THINNESS; VIETNAM; YOUNG ADULT;

EID: 84928347640     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.03.020     Document Type: Article

References (18)

1. Jean S.S., Hsueh P.R. High burden of antimicrobial resistance in Asia. International journal of antimicrobial agents 2011, 37:291-295.
2. Yahav D., Farbman L., Leibovici L., Paul M. Colistin: new lessons on an old antibiotic. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18:18-29.
3. Garonzik S.M., Li J., Thamlikitkul V., Paterson D.L., Shoham S., Jacob J., et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrobial agents and chemotherapy 2011, 55:3284-3294.
4. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American journal of infection control 2008, 36:309-332.
5. The Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. Approved Standard M100-S23. Wayne, PA: CLSI; 2013.
6. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases 1987, 40:373-383.
7. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Critical care medicine 1985, 13:818-829.
8. Pugin J., Auckenthaler R., Mili N., Janssens J.P., Lew P.D., Suter P.M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. The American review of respiratory disease 1991, 143:1121-1129.
9. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive care medicine 1996, 22:707-710.
10. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute Dialysis Quality Initiative w. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical care 2004, 8:R204-R212.
11. Ali T., Khan I., Simpson W., Prescott G., Townend J., Smith W., et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. Journal of the American Society of Nephrology: JASN 2007, 18:1292-1298.
12. Pickering J.W., Endre Z.H. GFR shot by RIFLE: errors in staging acute kidney injury. Lancet 2009, 373:1318-1319.
13. Pulluru H.K.K., Pogue J.M., Marchaim D., Hayakawa K. Risk factors for and incidence of nephrotoxicity associated with intravenous colistin in the modern era: a systematic review. Interscience Conference on Antimicrobial Agents and Chemotherapy 2012.
14. Dalfino L., Puntillo F., Mosca A., Monno R., Spada M.L., Coppolecchia S., et al. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2012, 54:1720-1726.
15. Deryke C.A., Crawford A.J., Uddin N., Wallace M.R. Colistin dosing and nephrotoxicity in a large community teaching hospital. Antimicrobial agents and chemotherapy 2010, 54:4503-4505.
16. Doshi N.M., Mount K.L., Murphy C.V. Nephrotoxicity associated with intravenous colistin in critically ill patients. Pharmacotherapy 2011, 31:1257-1264.
17. Pogue J.M., Lee J., Marchaim D., Yee V., Zhao J.J., Chopra T., et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2011, 53:879-884.
18. Paul M., Bishara J., Levcovich A., Chowers M., Goldberg E., Singer P., et al. Effectiveness and safety of colistin: prospective comparative cohort study. The Journal of antimicrobial chemotherapy 2010, 65:1019-1027.